Kura Oncology
KURA
KURA
185 hedge funds and large institutions have $686M invested in Kura Oncology in 2024 Q4 according to their latest regulatory filings, with 48 funds opening new positions, 70 increasing their positions, 36 reducing their positions, and 41 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
6.14% less ownership
Funds ownership: 107.48% → 101.34% (-6.1%)
57% less capital invested
Capital invested by funds: $1.61B → $686M (-$921M)
60% less funds holding in top 10
Funds holding in top 10: 5 → 2 (-3)
Holders
185
Holding in Top 10
2
Calls
$1.2M
Puts
$939K
Top Buyers
| 1 | +$38.8M | |
| 2 | +$27.4M | |
| 3 | +$18M | |
| 4 |
Millennium Management
New York
|
+$13.3M |
| 5 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
+$8.82M |
Top Sellers
| 1 | -$106M | |
| 2 | -$84.6M | |
| 3 | -$38.4M | |
| 4 |
CC
Commodore Capital
New York
|
-$35.2M |
| 5 |
SCM
Suvretta Capital Management
New York
|
-$22.4M |